Brett KlegerScientists with the Dominantly Inherited Alzheimer Network (DIAN) at the Washington University in St. Louis School of Medicine are undertaking five years of studies of a rare form of early-onset Alzheimer’s disease using a “bring your own device” (BYOD) study model.
Read moreAlzheimer’s Studies Adopt ‘Bring Your Own Device’ Strategy for Participants
The Washington University School of Medicine in Saint Louis has selected Datacubed Health’s mobile platform has been selected to support worldwide studies for those at risk of Dominantly Inherited Alzheimer’s Disease, a rare form of early-onset Alzheimer’s Disease. The Linkt platform enables the collection of real-time data on sleep, diet and other biomarkers using a “bring your own device” (BYOD) study model.
The Washington University School of Medicine in St. Louis is launching a five-year study that will use an mHealth app and connected health platform to monitor people living with Dominantly Inherited Alzheimer’s Disease.
Read moreAlzheimer’s Research Study to Use mHealth for Remote Monitoring
Datacubed Health’s Mobile Platform Selected to Improve Data Quality and Decrease Patient Burden in Five-Year Washington University Study
Read moreBYOD Technology Adopted for Alzheimer’s Observational Study
If used mindfully, the latest advances in technology could create a more comfortable environment in which we can begin to bring in underrepresented populations and reverse the lack of diversity in clinical trials.
Read moreLeveraging technology and digital tools to (finally) increase diversity in clinical trials
Scientists are to use an app to conduct the first crowdsourcing study on the impact of smartphone use on working memory, mental focus and attention.
Read moreStudy will gauge impact of smartphone on memory and focus
With the advent of large-scale databases that measure everything from credit-worthiness (a strong predictor of overall health), to individual social networks (a predictor of mental health), to air quality (a predictor of asthma), comprehensive pheno-typing is becoming practical.
Read moreUnleash the full potential of the Human Genome Project
‘Biopharma has a real opportunity to move quickly with remote, virtual trial technology,’ says Data Cubed’s new CCO
Read more‘The magic balance’: Diverse advisory boards guide clinical trial design
It will take a marriage between Silicon Valley and clinical trials expertise to drive innovation in the digital health space, which is being held back by uncertainty – and a reluctance that is keeping industry executives up at night.
Company rebrands to focus on clinical research and science